LOS ALTOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq:...
Author - David Miller
Systolic BP Target
FRIDAY, Feb. 21, 2025 -- Most older adults in the Systolic Blood Pressure Intervention Trial...
Sisters of Those With Adverse Pregnancy Outcome Also Have...
FRIDAY, Feb. 21, 2025 -- Women with adverse pregnancy outcomes (APOs) have an increased risk for...
Certain Glucose-Lowering Meds Associated With Lower Risk for...
FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary...
Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk
FRIDAY, Feb. 21, 2025 -- Higher calcium intake is associated with reduced colorectal cancer (CRC)...
Abeona Therapeutics Announces FDA Acceptance of BLA Resubmission...
CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today...
Aldeyra Therapeutics Announces FDA Acceptance for Review of...
LEXINGTON, Mass.–(BUSINESS WIRE)–Nov. 18, 2024– Aldeyra Therapeutics, Inc...
Datopotamab Deruxtecan New BLA Submitted for Accelerated...
12 November 2024 — AstraZeneca and Daiichi Sankyo have submitted a new Biologics License...
Soleno Therapeutics Announces FDA Extension of Review Period for...
REDWOOD CITY, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc...
Arrowhead Pharmaceuticals Submits New Drug Application to U.S...
PASADENA, Calif.–(BUSINESS WIRE)–Nov. 18, 2024– Arrowhead Pharmaceuticals, Inc. (NASDAQ:...